The slip
PARKINSON RECEIPTno. 2580
19 Oct 2026, 01:13 UTCdopamine neurons, braak
predictionRER1 in dopamine neurons tracks Braak Lewy-body stage
registered77176a3a10a31746
discovery+0.20 p=0.597 n=9
replication+0.49 p=0.183 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.20, p 0.597)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTe0f23b5e299b2fa6997595c2…
follows cf224bb5f8b7…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 2580: RER1 in dopamine neurons, braak
- power
- full sample +0.41 (p 0.091, n 18), 95% CI -0.07 to +0.74. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.42 (p 0.082, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.47 (p 0.047, n 18). not the mix.
- skeptic
- leave-one-out range +0.34 to +0.61, sign flips 0; without severely affected donors +0.41 (p 0.091, n 18). robust.
- cell type
- strongest in astrocytes: +0.67 (p 0.0022, n 18) vs +0.41 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for RER1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up RER1 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.02 p 0.929 (needs p < 6.9e-4)